Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about LILLY DRN

Recent news which mentions LILLY DRN

< Previous 1 2 3 Next >
Inside Isomorphic Labs, the secretive AI life sciences startup spun off from Google DeepMind
Tags Technology Breaking News: Technology US: News
From CNBC.com News
Trump says tariffs will accelerate reshoring, but experts say it's not that easy
Tags Politics LILLY DRN Investment strategy
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Biotechnology Novo Nordisk A/S Health care industry
From CNBC.com News
Europe's pharma industry braces for tariffs as carve-out hopes fade
Tags Biotech and Pharmaceuticals Pharmaceuticals Health & Science
From CNBC.com News
Hims & Hers shares rise as company adds new weight-loss medications to platform
Tags Enterprise LILLY DRN Breaking News: Technology
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
Tags LILLY DRN Moderna Inc Breaking News: Markets
From CNBC.com News
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Tags Health care industry AstraZeneca PLC Health & Science
From CNBC.com News
Eli Lilly sues two pharmacies making copycat Zepbound, Mounjaro
Tags Business News LILLY DRN Social issues
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Novo Nordisk A/S Biotechnology Health care industry
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Novo Nordisk A/S Biotechnology LILLY DRN
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags Biotechnology Novo Nordisk A/S LILLY DRN
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Investing Markets Economy
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Viking Therapeutics Inc LILLY DRN Business News
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Biotechnology Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Beijing pledges greater market access as top global CEOs gather at the China Development Forum
Tags China Politics Asia: Business U/S/ Markets
From CNBC.com News
Zepbound copycats remain online despite FDA ban
Tags Retail Hims & Hers Health Inc Business
From CNBC.com News
Roche and Zealand Pharma strike $5.3 billion deal for new obesity drug candidate
Tags Biotech and Pharmaceuticals Pharmaceuticals LILLY DRN
From CNBC.com News
White House: Stock market plunge is not as 'meaningful' as business activity
Tickers CEOS
Tags Political Leaders Economy Government and politics
From CNBC.com News
Amgen starts two critical late-stage trials for weight loss drug MariTide
Tags Biotech and Pharmaceuticals Health & Science Science
From CNBC.com News
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Tags Business US: News Companies
From CNBC.com News
Healthy Returns: AbbVie is the newest potential weight loss drug market player
Tags AstraZeneca PLC Salesforce Inc Biotech and Pharmaceuticals
From CNBC.com News
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
Tags Companies Business US: News
From CNBC.com News
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
Tags Pharmaceuticals Health care industry Biotechnology
From CNBC.com News
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
Tags Biotech and Pharmaceuticals Science Health & Science
From CNBC.com News
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Tags Amgen Inc LILLY DRN Health & Science
From CNBC.com News
Healthy Returns: Ozempic helps curb alcohol use in new study — and doctors are concerned about telehealth GLP-1s
Tags Health care industry Novo Nordisk A/S Health & Science
From CNBC.com News
Trump's reciprocal tariffs would hit these European Union products that Americans buy the hardest
Tags Europe Economy Politics LILLY DRN
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Markets Peloton Interactive Inc Investing
From CNBC.com News
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.